«Лучше меньше, да лучше»: новая философия применения витаминно-минеральных комплексов в период беременности и грудного вскармливания

Т. А. Ермоленко; Н. И. Турчин

doi:10.18370/2309-4117.2019.47.68-72

Authors

Т. А. Ермоленко Odesa National Medical University, Ukraine https://orcid.org/0000-0002-2806-7376
Н. И. Турчин Odesa National Medical University, Ukraine https://orcid.org/0000-0001-6421-6407

DOI:

https://doi.org/10.18370/2309-4117.2019.47.68-72

Keywords:

pregnancy, breastfeeding, vitamin and mineral complexes, micronutrients, Ogestan

Abstract

Need for micronutrients increases more than for macronutrients during pregnancy, and their inadequate intake with food can have significant consequences for mother and fetus. Many nutritional supplements containing vitamins, minerals and other trace elements are widely offered to women at all stages of pregnancy. But when choosing any vitamin and mineral complexes, it is extremely important to take into account the possibility of different types of interactions between vitamins, as well as between vitamins and macro- and/or microelements. Irrational use of large doses of vitamins during pregnancy carries risks that are almost comparable to their deficiency. Therefore, today multicomponent vitamin and mineral complexes are not recommended for routine use during pregnancy to improve maternal and perinatal outcomes. The modern tactics of their use in pregnant and lactating women is based on the position that any supplements can be useful only if they compensate for the identified deficit in specific micronutrients, which cannot be replenished with food.

Therefore, the optimal decision for prevention of micronutrient deficiencies in pregnant and lactating women is the use of a basic complex containing only those components whose deficit is scientifically proven. According to various expert organizations in pregnant and lactating women are increased need for folic acid, ω-3- fatty acids, iodine and vitamin D regardless of their nutritional status.

Based on the above principles and recommendations of international expert organizations, specialists of the Scientific Research Center Besins Healthcare developed a basic micronutrient complex Ogestan® to provide the physiological needs of the female body during the preparation for conception, pregnancy and breastfeeding. This is an addition to the daily diet of a pregnant and lactating woman with no clinical signs of any deficient conditions. It contains folic acid, docosahexaenoic acid, iodine, and vitamin D.

Author Biographies

Т. А. Ермоленко, Odesa National Medical University

MD, professor, Obstetrics and Gynecology Department No. 2

Н. И. Турчин, Odesa National Medical University

PhD, Department of professional pathology, clinical laboratory and functional diagnostics

References

Trumbo, P., Schlicker, S., Yates, A.A., Poos, M. “Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.” J Am Diet Assoc 102 (2002): 1621–30.
Gernand, A., et al. “Micronutrient deficiencies in pregnancy worldwide: health effects and prevention.” Nat Rev Endocrinol 12.5 (2016): 274–89. DOI: 10.1038/nrendo.2016.37
Burton, G.J., Jauniaux, E., Charnock-Jones, D.S. “Human early placental development: potential roles of the endometrial glands.” Placenta 28 Suppl. A (2007): S64–9.
Ших, Е.В. Витаминно-минеральный комплекс при беременности / Е.В. Ших, А.А. Махова. – М.: ГЭОТАР-Медиа, 2016.
Bourk, B., Last, W. Magnesium chloride for health and rejuvenation (2008). Available from: [https://www.mismo.com.au/Documents/Walter%20Last%20nexusarticle.pdf].
Serov, V.N., Torshin, I.Y., Gromova, O.A. “Trimester approach to the designation of vitamin and mineral complexes based on a systematic analysis of the biological significance of vitamins and trace elements in the mother-placenta-fetus system.” Gynecology 12.6 (2010): 24–34.
Shikh, E.V., Ilyenko, L.I. Clinical and pharmacological aspects of the vitamin and mineral complexes in pediatrics. Tutorial. Moscow: Medpractice-M (2008).
Obstetric Evidence Based Guidelines, 2nd edition. Ed. by V. Berghella. Informa Healthcare (2012).
World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: WHO (2017).
U. S. Food and Drug Administration online. “Fortify Your Knowledge About Vitamins.” Available from: [https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm118079.htm], last accessed May 21, 2019.
Harding, K.B., Peña-Rosas, J., Webster, A.C., et al. “Iodine supplementation for women during the preconception, pregnancy and postpartum period.” Cochrane Database Syst Rev 3 (2017): CD011761.
Morce, N.L. “Benefits of Docosahexaenoic Acid, Folic Acid, Vitamin D and Iodine on Foetal and Infant Brain Development and Function Following Maternal Supplementation during Pregnancy and Lactation.” Nutrients 4 (2012): 799–840.
Middleton, P., et al. “Omega-3 fatty acids addition during pregnancy.” Cochrane Database Syst Rev (2018). DOI: 10.1002/14651858.CD003402.pub3
European Food Safety Authority NDA Panel. “Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol.” EFSA J 8 (2010): 1–107.
FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition. Fats and Fatty Acids in Human Nutrition: Report of an Expert Consultation; 10–14 November 2008. Geneva: Food and Agriculture Organization of the United Nations (2010).
Lumley, J., Watson, L., Watson, M., Bower, C. “Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects.” Cochrane Database Syst Rev 3 (2001): CD0010.
Pietrzik, K., et al. “Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics.” Clin Pharmacokinet 49.8 (2010): 535–48.
Gromova, O.A., Torshin, I.Y., Tetruashvili, N.K., Limanov, O.A. “About new trends in nutritional support for pregnancy.” Obstetrics and gynecology 1 (2018): 21–8. DOI: 10.18565/aig.2018.1.21-28
Qi, Z., et al. “Prevalence of the C677T substitution of the methylentetrahydrofolate reductase (MTHFR) gene in Wisconsin.” Genetics in Medicine 5.6 (2003): 458–9.
Rai, V., Yadav, U., Kumar, P. “Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh.” Indian J Hum Genet 18.1 (2012): 43–6.
De Goes Solido, A., et al. “Prevalence of the MTHFR C677T Mutation in Fertile and Infertile Women.” Rev Bras Ginecol Obstet 39 (2017): 659–62.
Lecler, D., et al. Molecular Biology of Methylenetetrahydrofolate Reductase (MTHFR) and Overview of Mutations/Polymorphisms. Madame Curie Bioscience Database. Austin (TX): Landes Bioscience (2000–2013).
Crider, K.S., Bailey, L.B., Berry, R.J. “Folic acid food fortification-its history, effect, concerns, and future directions.” Nutrients 3.3 (2011): 370–84.
Chang, H., Zhang, T., Zhang, Z., et al. “Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects.” J Nutr Biochem 22.12 (2011): 1172–7.
FIGO Working Group. “Best practice in Maternal-Fetal Medicine.” Int J Gynaecol Obstet 128 (2015): 80–82.
Wagner, C.L., et al. “The role of vitamin D in pregnancy and lactation: emerging concepts.” Women’s Health (London) 8.3 (2012): 323–40.
Aghajafari, F., Field, C.J., Weinberg, A.R., Letourneau, N.; APrON Study Team. “Both Mother and Infant Require a Vitamin D Supplement to Ensure That Infants’ Vitamin D Status Meets Current Guidelines.“ Nutrients 10.4 (2018): 429. DOI: 10.3390/nu10040429
Hollis, B.W., Wagner, C.L. “Vitamin D requirements during lactation: High-dose maternal supplementation during lactation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant.” Am J Clin Nutr 80 (2004): 1752S–1758S.
Wagner, C.L., Hulsey, T.C., Fanning, D. Et al. “High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: A 6-month follow-up pilot study.” Breastfeed Med 1 (2006): 59–70.
Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc: a Report of the Panel on Micronutrients. Washington, DC: National Academy Press (2001).
Chitayat, D., et al. “Folic Acid Supplementation for Pregnant Women and Those Planning Pregnancy: 2015 Update.” The Journal of Clinical Pharmacology 56.2 (2016): 170–5.
Andersson, M., De Benoist, B., Delange, F., Zupan, J. “Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: Conclusions and recommendations of the Technical Consultation.” Public Health Nutrition 10.12A (2007): 1606–11.